Egypt Gynecology
Drugs Market is expected to grow at a significant rate during the forecast
period. Egypt has a growing pharmaceutical industry and is one of the largest
markets for pharmaceuticals in the Middle East and North Africa (MENA) region.
The gynecology drugs market in the country is expected to continue to grow due
to the increasing prevalence of gynecological diseases and disorders, a growing
female population, and rising awareness and education among women about their
health and well-being.
The market for
gynecology drugs in Egypt is regulated by the Ministry of Health and
Population, which is responsible for overseeing the approval and registration
of new drugs and ensuring the safety and quality of pharmaceutical products.
The government of Egypt also provides subsidies for some essential drugs,
including those used in the treatment of gynecological conditions. These
factors are fueling the demand for the gynecology drugs market in Egypt.
Some of the
leading companies operating in the Egypt gynecology drugs market are Pfizer,
Bayer, MSD, Novartis, and Sanofi. These companies offer a range of products for
the treatment of various gynecological diseases and conditions, such as
hormonal disorders, infections, and even cancer.
Overall, the
gynecology drugs market in Egypt is expected to remain proliferating in the
coming years due to increasing demand for these drugs and the rising government
support for the pharmaceutical industry. However, it is important to note that
market conditions can change rapidly, and the information provided here may not
reflect the current situation.
Prevalence of
Gynecological Diseases and Disorders Drives Market
The increasing prevalence of
gynecological diseases and disorders among female population is the key driving
force behind the growth of the Egypt gynecology drugs market. The rising
incidence of these disorders is leading to a higher demand for gynecology drugs
and treatments. For instance, cervical cancer has surfaced as one of the most
common types of cancer affecting women in Egypt. According to the World
Health Organization (WHO), Cervical cancer is the 6th most common cancer in
women in the Eastern Mediterranean Region. In 2020, an estimated 89,800 women
were diagnosed with cervical cancer in the Region and more than 47,500 women
died from the disease. Moreover, according to the latest WHO data,
published in 2020, the deaths caused by ovarian cancer reached 1,944 or 0.36%
of total deaths in Egypt. The age-adjusted death rate is 5.11 per 100,000
population, placing Egypt at 61st position in the world. This
has led to an increased demand for drugs and treatments to prevent and treat
cervical cancer. Other gynecological conditions, such as breast cancer, ovarian
cancer, endometriosis, and uterine fibroids, are also becoming more prevalent
in the country, fueling the demand for drugs and treatments to manage and treat
these conditions.
As a result, pharmaceutical
companies are investing in research and development to prepare new and more
effective drugs and treatments for gynecological conditions. This factor is
likely to propel the gynecology drugs market in Egypt in the coming years.
Download Free Sample Report
Growing Female Population
Boosts Demand for Egypt Gynecology Drugs market
The growing female population
in Egypt is another important driver in the country’s gynecology drugs market.
As the female population grows, so does the demand for gynecology drugs and
treatments. According to the World Bank, the female population in Egypt was
estimated to be around 53,107.73 billion in 2020, accounting for around 49.4%
of the total population. This is a significant market for gynecology drugs
and treatments, as women require healthcare services throughout their lives,
including contraception, prenatal care, and treatment for gynecological
conditions. Furthermore, as women in this country become more aware of
their health and well-being, they are increasingly seeking out healthcare
services and products, including gynecology drugs and treatments. This is
leading to a higher demand for these products and driving the gynecology drugs
market.
Over the coming years, the
growing female population in Egypt is expected to continue to boost the demand
for gynecology drugs and treatments, making it an important driver of market
expansion.
Rising Disposable Income Fuel
Egypt Gynecology Drugs Market Expansion
The rising
disposable income is another factor contributing to the growth of the
gynecology drugs market in Egypt. With increasing disposable income, people here
can afford better healthcare services, including gynecology drugs and
treatments. As the economy grows, people are experiencing increased purchasing
power and higher standards of living, which is leading to increased spending on
healthcare. This is particularly true for women, who often prioritize their
health and well-being, including gynecological health. With increased
disposable income, women in Egypt can afford a wider range of gynecology drugs
and treatments, including more expensive and advanced options. This is driving
demand for these products and contributing to the growth of the Egypt gynecology
drugs market.
In addition, as
the healthcare system in Egypt improves and becomes more accessible, people are
increasingly seeking out healthcare services and products, including gynecology
drugs and treatments. This is further fueling demand for these products and
driving the expansion of the gynecology drugs market in Egypt. Overall, the rising
disposable income is expected to continue to drive demand for gynecology drugs
and treatments in Egypt during the forecast period, making it an important
factor in the market expansion.
Technological Advancements
in Gynecology Drugs Market
Technological
advancements are also a significant driver of the gynecology drugs market in
Egypt. Technological advancements are leading to the development of new and
more effective gynecology drugs and treatments, boosting their demand in the
market. For example, there have been significant developments in the use of
hormonal therapies for the treatment of gynecological conditions, such as
endometriosis and uterine fibroids. These therapies are highly effective in
reducing symptoms and improving the quality of life for women with these
conditions. In addition, there has been an increasing focus on personalized
medicine and precision medicine approaches, which aim to provide targeted and
individualized treatments based on a patient's specific needs and
characteristics. This has led to the development of new drugs and treatments
that are tailored to the unique needs of individual patients. Furthermore,
advancements in diagnostic technologies, such as imaging and genetic testing,
are improving the ability to detect and diagnose gynecological conditions at an
early stage. This allows for earlier intervention and more effective treatment,
which can improve patient outcomes.
Overall,
technological advancements are facilitating the development of new and more
effective gynecology drugs and treatments to meet the needs of patients in
Egypt. However,
the regulatory environment for pharmaceuticals in the country can be complex
and challenging to navigate. The regulatory process for drug approvals is time-consuming
and expensive, which can impact the ability of pharmaceutical companies to
bring new drugs to market. Hence, this factor is expected to hamper the growth
of this market.
Market Segmentation
The Egypt gynecology drugs market
is analyzed on the basis of therapeutics, indication, and distribution channels.
Based on therapeutics,
the market is divided into non-hormonal therapy vs. hormonal therapy.
Based on indication, the market is divided into contraception, gynecology infections,
female infertility, postmenopausal disorders, polycystic ovary syndrome, osteoporosis,
gynecology cancer, endometriosis, and others. Based on distribution channels, the
market is divided into retail pharmacies, hospital pharmacies, and online pharmacies.
Market players
Amgen Inc., F.
Hoffmann - La Roche Ltd. Roche Egypt LLC, Novartis Egypt, Bayer AG, Merck &
Co., Inc., Eli Lilly and Company, Pfizer Inc., Abbott Laboratories, AbbVie
Inc., GlaxoSmithKline Plc, AstraZeneca Plc, Johnson and Johnson, Sanofi Egypt, Ferring
Pharmaceuticals are some of the key players in the Egypt gynecology drugs
market.
|
Attribute
|
Details
|
|
Base
Year
|
2022
|
|
Historic
Data
|
2018 –
2021
|
|
Estimated
Year
|
2023
|
|
Forecast
Period
|
2024 – 2028
|
|
Quantitative
Units
|
Revenue in USD Million, and CAGR for 2018-2022 and 2023-2028
|
|
Report
Coverage
|
Revenue
forecast, company share, competitive landscape, growth factors, and trends
|
|
Segments
Covered
|
Therapeutics
Indication
Distribution
Channel
|
|
Regional
scope
|
Cairo, Alexandria,
Giza Qalyubia, Port Said Suez, Rest of Egypt.
|
|
Key
companies profiled
|
Amgen
Inc., F. Hoffmann - La Roche Ltd. Roche Egypt LLC, Novartis Egypt, Bayer AG,
Merck & Co., Inc., Eli Lilly and Company, Pfizer Inc., Abbott
Laboratories, AbbVie Inc., GlaxoSmithKline Plc, AstraZeneca Plc, Johnson and
Johnson, Sanofi Egypt, Ferring Pharmaceuticals.
|
|
Customization
scope
|
10% free
report customization with purchase. Addition or alteration to country,
regional & segment scope.
|
|
Pricing
and purchase options
|
Avail
customized purchase options to meet your exact research needs. Explore purchase options
|
|
Delivery
Format
|
PDF and
Excel through Email (We can also provide the editable version of the report
in PPT/Word format on special request)
|
Report Scope:
In this report, the Egypt gynecology
drugs market has been segmented into the following categories, in addition to
the industry trends which have also been detailed below:
Egypt Gynecology Drugs Market, By Therapeutics:
o Non-Hormonal Therapy
o Hormonal Therapy
Egypt Gynecology Drugs Market, By Indication:
o Contraception
o Gynecology Infections
o Female Infertility
o Postmenopausal disorders
o Polycystic Ovary Syndrome
o Gynecology Cancers
o Endometriosis
Egypt Gynecology Drugs Market, By Distribution Channel:
o Retail Pharmacies
o Hospital Pharmacies
o Online Pharmacies
Egypt Gynecology Drugs market, By Region:
o Cairo
o Alexandria
o Giza Qalyubia
o Port Said Suez
o Rest of Egypt
Competitive Landscape
Company
Profiles: Detailed
analysis of the major companies present in the Egypt Gynecology Drugs market.
Available Customizations:
With the given market data, TechSci
Research offers customizations according to a company’s specific needs. The following
customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
Egypt Gynecology Drugs market is an
upcoming report to be released soon. If you wish an early delivery of this
report or want to confirm the date of release, please contact us at [email protected]